Fibro-adipose vascular anomaly
| Fibro-adipose vascular anomaly | |
|---|---|
| Synonyms | FAVA |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Pain, swelling, muscle contracture |
| Complications | Chronic pain, limb dysfunction |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | Unknown |
| Diagnosis | MRI, Ultrasound |
| Differential diagnosis | Venous malformation, Lymphatic malformation, Arteriovenous malformation |
| Prevention | N/A |
| Treatment | Sclerotherapy, Surgical resection, Pain management |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
A rare vascular anomaly
| Fibro-adipose vascular anomaly | |
|---|---|
| Synonyms | N/A |
| Pronounce | |
| Specialty | Pediatrics, Interventional radiology, Vascular surgery, Orthopedics |
| Symptoms | Chronic pain, swelling, difficulty moving the affected limb, contracture, mild enlargement of the affected limb |
| Complications | Mobility impairment, muscle atrophy, reduced quality of life |
| Onset | Later childhood to young adulthood |
| Duration | Chronic |
| Types | |
| Causes | Unknown; may involve somatic mutations, including PIK3CA gene variants |
| Risks | Possibly sporadic mutations; no clear inheritance pattern |
| Diagnosis | Ultrasound, MRI, biopsy, clinical examination |
| Differential diagnosis | Venous malformation, Klippel–Trénaunay syndrome, lipofibromatosis, intramuscular hemangioma |
| Prevention | None known |
| Treatment | Physical therapy, surgical resection, cryoablation, sclerotherapy |
| Medication | Sirolimus (off-label), NSAIDs for pain |
| Prognosis | Variable; symptoms often manageable but may be progressive |
| Frequency | Rare |
| Deaths | Extremely rare; not typically fatal |
Fibro-adipose vascular anomaly (FAVA) is a rare and complex vascular anomaly characterized by the presence of fibrous and adipose (fatty) tissue within the muscles, often accompanied by pain and swelling. This condition primarily affects the extremities, such as the arms and legs, and is most commonly diagnosed in children and young adults.
Clinical Presentation[edit]
Patients with fibro-adipose vascular anomaly typically present with a combination of symptoms, including:
- Persistent pain in the affected limb
- Swelling and tenderness
- Limited range of motion
- Muscle weakness
- Skin changes over the affected area
The pain associated with FAVA is often severe and can significantly impact the patient's quality of life. The condition may be mistaken for other musculoskeletal disorders due to its overlapping symptoms.
Pathophysiology[edit]
Fibro-adipose vascular anomaly is characterized by the abnormal proliferation of fibrous tissue, adipose tissue, and vascular malformations within the muscle. The exact cause of FAVA is not well understood, but it is believed to involve a combination of genetic and environmental factors. The vascular malformations in FAVA are typically composed of dysplastic veins and lymphatic vessels.
Diagnosis[edit]
The diagnosis of FAVA is primarily based on clinical evaluation and imaging studies. Magnetic resonance imaging (MRI) is the preferred imaging modality, as it can clearly delineate the extent of the fibrous and adipose tissue infiltration and identify associated vascular anomalies. Ultrasound and computed tomography (CT) scans may also be used to assess the condition.
Treatment[edit]
Management of fibro-adipose vascular anomaly is challenging and often requires a multidisciplinary approach. Treatment options include:
- Pain management with analgesics and anti-inflammatory drugs
- Physical therapy to maintain mobility and muscle strength
- Surgical intervention to remove fibrous and adipose tissue, if feasible
- Sclerotherapy or embolization to address vascular malformations
The choice of treatment depends on the severity of symptoms, the extent of the anomaly, and the patient's overall health.
Prognosis[edit]
The prognosis for individuals with fibro-adipose vascular anomaly varies. While some patients may experience significant relief from symptoms following treatment, others may continue to have chronic pain and functional limitations. Early diagnosis and intervention are crucial for improving outcomes.
Related Pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


